Alpenglow Biosciences Analysis: $24M Raised
What is Alpenglow Biosciences?
AI-enabled 3D tissue imaging for drug development and diagnostics
Location
Seattle, United States
Employees
11-50
Founded
2018
Product Features & Capabilities
- Aurora 3D Spatial Biology Solution
- 3Di™ HOTLS - 3D Imaging Microscope
- 3Dm™ - Data Management
- 3Dai™ - Image Analysis
- 3D Histology Imaging Services
Use Cases
Quantify immune cell infiltration in tumor microenvironments; Analyze nerve and immune cell structures in skin biopsies; Map cellular networks across multi-field tissue samples; Measure cell populations and distances in intact 3D tissue; Generate ground-truth 3D data for model training; Support 3D RNA imaging in research settings
Other Considerations
Five of the top 10 pharmaceutical companies use the platform; Partnerships with Virdx, Molecular Instruments, and Zeiss; Recognized in 3D Imaging World Cup 2025; Provides ground-truth 3D data for AI model training; Preserves tissue for additional molecular analysis after imaging
See something that needs updating? Suggest edits to this profile.